|
CN111904942A
|
|
Topiramate dry suspension, preparation method and application thereof
|
|
WO2020244615A1
|
|
Lacosamide pharmaceutical composition and pharmaceutical preparation thereof
|
|
CN111388428A
|
|
Topiramate sustained-release preparation, preparation method and application thereof
|
|
CN111481521A
|
|
Oxcarbazepine sustained release preparation, preparation method and application thereof
|
|
CN110575611A
|
|
quantitative rectal syringe
|
|
CN110869003A
|
|
Preservative-free solid-dosage vigabatrin pharmaceutical composition
|
|
WO2020155507A1
|
|
Preservative-free vigabatrin pharmaceutical composition in solid dosage form
|
|
US2019060237A1
|
|
Powder for oral suspension containing lamotrigine
|
|
CN107281094A
|
|
A kind of timolol maleate Pharmaceutical composition and preparation method thereof
|
|
CN107213130A
|
|
A kind of Entecavir Pharmaceutical composition, preparation method and applications
|
|
CN106491539A
|
|
A kind of lamotrigine dry suspension and preparation method thereof
|
|
CN106619531A
|
|
Preparation method of stable oral slow-release suspension
|
|
CN104116715A
|
|
High-drug loading capacity oxcarbazepine controlled-release granule and preparation method thereof
|
|
CN103271888A
|
|
Pregabalin orally disintegrating tablet and dispersible tablet and preparation method thereof
|
|
CN103040785A
|
|
Permeable gastric retention tablets and preparation method thereof
|
